Esperion Therapeutics
ESPR
#6506
Rank
S$1.05 B
Marketcap
S$4.10
Share price
0.00%
Change (1 day)
29.13%
Change (1 year)

Market capitalization of Esperion Therapeutics (ESPR)

Last known market cap: S$1.05 Billion

As of November 2026 Esperion Therapeutics has a market cap of S$1.05 Billion. This makes Esperion Therapeutics the world's 6506th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Esperion Therapeutics from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$1.05 B-14.03%
2025S$1.22 B101.37%
2024S$0.61 B35.98%
2023S$0.44 B-27.03%
2022S$0.61 B49.49%
2021S$0.41 B-53.82%
2020S$0.89 B-59.68%
2019S$2.21 B31.14%
2018S$1.68 B-26.93%
2017S$2.30 B464.5%
2016S$0.40 B-42.36%
2015S$0.70 B-34.78%
2014S$1.08 B307.05%
2013S$0.26 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
S$201.46 B 18,958.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
S$122.86 B 11,522.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
S$2.16 B 104.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$0.87 B-16.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
S$5.86 B 455.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$15.09 B 1,327.90%๐Ÿ‡บ๐Ÿ‡ธ USA